Rong Bing Yang

Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

Ethypharm SAS is a holding company, which engages in developing pharmaceutical products. It offers treatment for pain and addiction, as well as complex generic drugs. The company was founded by G?rard Leduc and Patrice Debregreas in 1977 and is headquartered in Saint-Cloud, France.

Roquette Frères SA manufactures and produces plant based-ingredients such as protein, fiber, polyols, starches, cereal sugars, cyclodextrins, and organic acids. It serves to pharmaceutical, cosmetics, food, nutrition, animal nutrition, and industrial sectors. The company was founded by Dominique Roquette and Germain Roquette in 1933 and is headquartered in Lestrem, France.

Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK.

Part of Etypharm, Prographarm is a specialty hospital that provides non-psychiatric medical services. The company is based in Chateauneuf-en-Thymerais, France. Prographarm was acquired by Etypharm on August 01, 1999.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Program for Appropriate Technology in Health provides social healthcare services. Its platform includes vaccines, drugs, diagnostics and devices. The firm offers treatment for malaria, pneumonia and diarrheal. The company was founded in 1977 and is headquartered in Seattle, WA.

SIS Medical AG develops, produces and distributes products for the treatment of vascular diseases. The firm is improving and prolonging human life within the field of minimal invasive therapy. The company was founded by Willi Zwahlen and Michael Schwage and is headquartered in Winterthur, Switzerland.

Luye Pharma Switzerland AG manufactures and distributes pharmaceutical products. The company is headquartered in Basel, Switzerland.